What were RAPT Therapeutics' revenue and net loss for Q2 2025 and the six‑month period, and how do these figures compare to consensus estimates?
Answer
The excerpt you provided from RAPT Therapeutics’ second‑quarter 2025 earnings release does not contain the actual financial figures (revenue, net loss) for either the quarter or the six‑month period, nor does it disclose the consensus analyst estimates against which those results would be compared.
Because the specific numbers are absent from the supplied text, it isn’t possible to state:
- Quarter‑over‑quarter (Q2 2025) revenue
- Quarter‑over‑quarter (Q2 2025) net loss
- Six‑month (January – June 2025) revenue
- Six‑month (January – June 2025) net loss
… nor to describe how those results stacked up against Wall Street’s consensus expectations.
What you can do next
Locate the full press release – The complete earnings announcement (usually posted on the company’s investor‑relations website or on the GlobeNewswire page) will list the exact revenue and net‑loss numbers for Q2 2025 and the six‑month period, as well as the consensus estimates from analysts (e.g., FactSet, Refinitiv, Bloomberg).
Check earnings‑summary services – Financial news platforms such as Yahoo Finance, Bloomberg, or Seeking Alpha typically publish a “Earnings Summary” that includes both the reported figures and the consensus estimates, highlighting any upside or downside surprises.
Consult the SEC filing – The company’s Form 10‑Q for the quarter (filed with the U.S. Securities and Exchange Commission) will also contain the detailed income‑statement figures and any discussion of how the results compare to analyst expectations.
Once you have the concrete numbers, you can easily compare:
| Period | Reported Revenue | Consensus Revenue Estimate | Revenue Surprise | Reported Net Loss | Consensus Net‑Loss Estimate | Net‑Loss Surprise |
|---|---|---|---|---|---|---|
| Q2 2025 | $ … | $ … | +/- % | $ … | $ … | +/- % |
| 6‑month (Jan‑Jun 2025) | $ … | $ … | +/- % | $ … | $ … | +/- % |
Positive or negative “surprise” percentages are calculated as ((Reported – Estimate) ÷ Estimate) × 100%.
Bottom line
Based solely on the snippet you shared, the exact revenue and net‑loss figures for RAPT Therapeutics’ Q2 2025 and six‑month results, as well as the consensus estimates, are not disclosed. To answer the question fully, you’ll need to retrieve the complete earnings release or the related SEC filing where those numbers are reported.